A PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SYNB1934 IN PATIENTS WITH PKU (SYNPHENY-3)

Registry ID

SYNB1934-CP-003

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE3

Study type

INTERVENTIONAL

Sponsor

SYNLOGIC OPERATING COMPANY INC.

Start date

2023-07-06

Last update

2023-04-05

Conditions

• PHENYLKETONURIA

Related clinical trials

• A PHASE 3, DOUBLE-BLIND, RANDOMIZED, TWO-PERIOD, MULTICENTER, PLACEBO CONTROLLED, EFFICACY AND SAFETY STUDY OF JNT-517 FOR THE TREATMENT OF PARTICIPANTS WITH PHENYLKETONURIA

View on source registry